Literature DB >> 28289177

Structural diversity of human gastric mucin glycans.

Chunsheng Jin1, Diarmuid T Kenny1, Emma C Skoog1, Medéa Padra1, Barbara Adamczyk1, Varvara Vitizeva1, Anders Thorell2, Vignesh Venkatakrishnan1, Sara K Lindén3, Niclas G Karlsson4.   

Abstract

The mucin O-glycosylation of 10 individuals with and without gastric disease was examined in depth in order to generate a structural map of human gastric glycosylation. In the stomach, these mucins and their O-glycosylation protect the epithelial surface from the acidic gastric juice and provide the first point of interaction for pathogens such as Helicobacter pylori, reported to cause gastritis, gastric and duodenal ulcers and gastric cancer. The rational of the present study was to map the O-glycosylation that the pathogen may come in contact with. An enormous diversity in glycosylation was found, which varied both between individuals and within mucins from a single individual: mucin glycan chain length ranged from 2-13 residues, each individual carried 34-103 O-glycan structures and in total over 258 structures were identified. The majority of gastric O-glycans were neutral and fucosylated. Blood group I antigens, as well as terminal α1,4-GlcNAc-like and GalNAcβ1-4GlcNAc-like (LacdiNAc-like), were common modifications of human gastric O-glycans. Furthemore, each individual carried 1-14 glycan structures that were unique for that individual. The diversity and alterations in gastric O-glycosylation broaden our understanding of the human gastric O-glycome and its implications for gastric cancer research and emphasize that the high individual variation makes it difficult to identify gastric cancer specific structures. However, despite the low number of individuals, we could verify a higher level of sialylation and sulfation on gastric O-glycans from cancerous tissue than from healthy stomachs.
Copyright © 2017, The American Society for Biochemistry and Molecular Biology.

Entities:  

Keywords:  Bioinformatics; Cancer Biology*; Gastric mucins; Gastrointestinal disease; Glycomics; Mass Spectrometry; O-glycan

Year:  2017        PMID: 28289177     DOI: 10.1074/mcp.M117.067983

Source DB:  PubMed          Journal:  Mol Cell Proteomics        ISSN: 1535-9476            Impact factor:   5.911


  4 in total

Review 1.  Analysis of Mammalian O-Glycopeptides-We Have Made a Good Start, but There is a Long Way to Go.

Authors:  Zsuzsanna Darula; Katalin F Medzihradszky
Journal:  Mol Cell Proteomics       Date:  2017-11-21       Impact factor: 5.911

2.  Use of Recombinant Mucin Glycoprotein to Assess the Interaction of the Gastric Pathogen Helicobacter pylori with the Secreted Human Mucin MUC5AC.

Authors:  Ciara Dunne; Anthony McDermot; Kumar Anjan; Aindrias Ryan; Colm Reid; Marguerite Clyne
Journal:  Bioengineering (Basel)       Date:  2017-04-15

3.  Sample handling of gastric tissue and O-glycan alterations in paired gastric cancer and non-tumorigenic tissues.

Authors:  Barbara Adamczyk; Chunsheng Jin; Karol Polom; Pedro Muñoz; Miguel A Rojas-Macias; David Zeeberg; Mats Borén; Franco Roviello; Niclas G Karlsson
Journal:  Sci Rep       Date:  2018-01-10       Impact factor: 4.379

4.  Aeromonas salmonicida binds α2-6 linked sialic acid, which is absent among the glycosphingolipid repertoires from skin, gill, stomach, pyloric caecum, and intestine.

Authors:  John Benktander; Henrik Sundh; Sinan Sharba; Susann Teneberg; Sara K Lindén
Journal:  Virulence       Date:  2022-12       Impact factor: 5.428

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.